Ardent Health Partners, LLC (ARDT)
$
9.39
+0.15 (1.60%)
Key metrics
Financial statements
Free cash flow per share
1.8075
Market cap
1.3 Billion
Price to sales ratio
0.2126
Debt to equity
1.3429
Current ratio
1.9673
Income quality
2.2698
Average inventory
120.1 Million
ROE
0.1015
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Ardent Health Partners, LLC owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. The operating expenses amount to $5,843,052,000.00 encompassing various operational costs incurred as the company manages its facilities. Highlighting its financial health, the company reported an income before tax of $286,358,000.00 showcasing its pre-tax profitability and ability to generate earnings. The total costs and expenses for the company are $5,998,755,000.00 reflecting its overall spending and investment in healthcare services. This financial data pertains to the fiscal year 2025 illustrating the company's performance over that period. Additionally, the weighted average number of shares outstanding is 140,760,736.00 highlighting the company's shareholder base and their involvement in its growth and success. Ardent Health Partners, LLC, founded in 2001 and based in Brentwood, Tennessee, is a subsidiary of EGI-AM Investments, L.L.C., establishing a firm foundation in the healthcare sector. In the broader market context, the stock is affordable at $12.82 suitable for budget-conscious investors looking for viable opportunities. Furthermore, the stock has a low average trading volume of 426,573.00 indicating lower market activity which may focus investor interest on the company’s long-term potential. With a mid-range market capitalization of $1,344,532,315.00 the company is a steady performer in its field. It is a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape and enhancing the quality of healthcare services available. Additionally, it belongs to the Healthcare sector, driving innovation and growth within the healthcare framework as it continues to evolve amidst changing market demands.
Is Ardent Health Partners, LLC (ARDT) a good investment?
Investing in Ardent Health Partners, LLC (ARDT) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bearish outlook. Always conduct your own research before investing.
What is Ardent Health Partners, LLC (ARDT)'s stock forecast?
Analysts predict Ardent Health Partners, LLC stock to fluctuate between $8.07 (low) and $15.48 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Ardent Health Partners, LLC's market capitalization?
As of 2026-03-13, Ardent Health Partners, LLC's market cap is $1,344,532,315, based on 143,187,680 outstanding shares.
How can I buy Ardent Health Partners, LLC (ARDT) stock?
To buy Ardent Health Partners, LLC (ARDT) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ARDT. Place an order (Market, Limit, etc.).
What is the best time to invest in Ardent Health Partners, LLC?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
How did Ardent Health Partners, LLC perform in the last earnings report?
Revenue: $6,324,339,000 | EPS: $0.96 | Growth: -39.62%.
Where can I find Ardent Health Partners, LLC's investor relations reports?
Visit https://www.ardenthealth.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Ardent Health Partners, LLC?
You can explore historical data from here
What is the all-time high and low for Ardent Health Partners, LLC stock?
All-time high: $20.72 (2024-10-16) | All-time low: $8.07 (2026-01-30).
What are the key trends affecting Ardent Health Partners, LLC stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
businesswire.com
NEW YORK--(BUSINESS WIRE)---- $ARDT #ARDT--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) and reminds investors of the March 9, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has.
globenewswire.com
SAN FRANCISCO, March 09, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is notifying investors in Ardent Health, Inc. (NYSE: ARDT) regarding the March 9, 2026, lead plaintiff deadline in a pending securities class action the company and certain of its top executives. CLICK HERE TO SUBMIT YOUR ARDT LOSSES The litigation focuses on the revelation in Nov. 2025 that Ardent alleged utilized a rigid 180-day cliff to reserve for uncollectible accounts – a process that the complaint alleges conflicts with prior assurances that it used “detailed reviews of historical collections” to value its receivables.
globenewswire.com
LOS ANGELES, March 09, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ardent Health, Inc. (“Ardent” or “the Company”) (NYSE: ARDT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before March 9, 2026.
prnewswire.com
LOS ANGELES, March 9, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ardent Health, Inc. ("Ardent" or "the Company") (NYSE: ARDT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 18, 2024 and November 12, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before March 9, 2026.
prnewswire.com
LOS ANGELES, March 9, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Ardent Health, Inc. ("Ardent " or "the Company") (NYSE: ARDT ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of ARDT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.
newsfilecorp.com
New York, New York--(Newsfile Corp. - March 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024 and November 12, 2025, both dates inclusive (the "Class Period"), of the important March 9, 2026 lead plaintiff deadline. SO WHAT: If you purchased Ardent Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
globenewswire.com
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Ardent Health (ARDT) To Contact Him Directly To Discuss Their Options
globenewswire.com
NEW YORK, March 08, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Ardent Health, Inc. (NYSE: ARDT) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Ardent securities between July 18, 2024 and November 12, 2025, both dates inclusive (the “Class Period”).
globenewswire.com
NEW YORK, March 08, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024 and November 12, 2025, both dates inclusive (the “Class Period”), of the important March 9, 2026 lead plaintiff deadline. SO WHAT: If you purchased Ardent Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
newsfilecorp.com
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardent To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Ardent between July 18, 2024 and November 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - March 8, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ardent Health, Inc. ("Ardent" or the "Company") (NYSE: ARDT) and reminds investors of the March 9, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
See all news
